The Technical Field "ウイルス" had 61 patent application filings in the most recent period (2023-01-01 to 2023-02-28). This is a significantly decreased of -338 filings (-84.7%) over 399 they had in the same period of the previous year (2022-01-01 to 2022-02-28). This report also includes technical terms related to " ろ過性病原体 ", " ろ過性菌 ", " 濾過性病原体 ", " 濾過性菌 ", " ウィルス ", " ビールス " in the search set.
The highest number of filings in 2021 with 3,702 cases, and their lowest number in 2014 with 1,924 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 13,635 cases in total) is 2,272, and the median is 2,377. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 2,272 patents |
Std Dev | 1,053 |
COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
Year | Cases | YOY |
---|---|---|
2022 year | 2,168 cases | -41.4 % |
2021 year | 3,702 cases | +31.7 % |
2020 year | 2,810 cases | +20.14 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ウイルス for the period of the last 10 years (2014-01-01 to 2024-10-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ウイルス, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of ウイルス over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 22,664 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ウイルス are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 19 cases, followed by ギリアードサイエンシーズインコーポレイテッド with 12 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 19 cases |
ギリアードサイエンシーズインコーポレイテッド | 12 cases |
ジェネンテックインコーポレイテッド | 11 cases |
ノバルティスアーゲー | 9 cases |
エフホフマン-ラロシュアーゲー | 7 cases |
ブリストル-マイヤーズスクイブカンパニー | 5 cases |
グラクソスミスクラインバイオロジカルズソシエテアノニム | 5 cases |
バーテックスファーマシューティカルズインコーポレイテッド | 2 cases |
アメリカ合衆国 | 1 cases |
Comparing the number of applications of each company, ギリアードサイエンシーズインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 215 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 190 cases.
Name | Cases |
---|---|
ギリアードサイエンシーズインコーポレイテッド | 215 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 190 cases |
エフホフマン-ラロシュアーゲー | 179 cases |
ノバルティスアーゲー | 178 cases |
ブリストル-マイヤーズスクイブカンパニー | 145 cases |
ジェネンテックインコーポレイテッド | 112 cases |
グラクソスミスクラインバイオロジカルズソシエテアノニム | 69 cases |
アメリカ合衆国 | 64 cases |
メルク・シャープ・アンド・ドーム・コーポレーション | 38 cases |
バーテックスファーマシューティカルズインコーポレイテッド | 34 cases |
メルク・シャープ・エンド・ドーム・コーポレイション | 1 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ウイルス are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 19 cases, followed by ギリアードサイエンシーズインコーポレイテッド with 12 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 19 cases |
ギリアードサイエンシーズインコーポレイテッド | 12 cases |
ノバルティスアーゲー | 9 cases |
エフホフマン-ラロシュアーゲー | 7 cases |
ブリストル-マイヤーズスクイブカンパニー | 5 cases |
アメリカ合衆国 | 1 cases |
Among the top coapplicants, ギリアードサイエンシーズインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 215 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 190 cases.
Name | Cases |
---|---|
ギリアードサイエンシーズインコーポレイテッド | 215 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 190 cases |
エフホフマン-ラロシュアーゲー | 179 cases |
ノバルティスアーゲー | 178 cases |
ブリストル-マイヤーズスクイブカンパニー | 145 cases |
アメリカ合衆国 | 64 cases |
メルク・シャープ・アンド・ドーム・コーポレーション | 38 cases |
Below is a ranking of the number of JP patent applications by ウイルス’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by ウイルス’s top 7 coapplicants over the last 20 years.
ウイルス filed 178 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 84 cases in total) is 14.0, and the median is 11.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 36 cases, and their lowest number in 2022 with 9 cases.
Index | Value |
---|---|
Average | 14.0 patents |
Std Dev | 10.5 |
COV | 0.8 |
Year | Cases | YOY |
---|---|---|
2022 year | 9 cases | -18.18 % |
2021 year | 11 cases | 0 |
2020 year | 11 cases | -42.1 % |
ウイルス filed 179 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 69 cases in total) is 11.5, and the median is 12.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 40 cases, and their lowest number in 2022 with 7 cases.
Index | Value |
---|---|
Average | 11.5 patents |
Std Dev | 6.8 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 7 cases | -50.0 % |
2021 year | 14 cases | -33.3 % |
2020 year | 21 cases | +110 % |
ウイルス filed 64 joint applications with アメリカ合衆国 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 24 cases in total) is 4.0, and the median is 3.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 17 cases, and their lowest number in 2022 with 1 cases.
Index | Value |
---|---|
Average | 4.0 patents |
Std Dev | 3.4 |
COV | 0.9 |
Year | Cases | YOY |
---|---|---|
2022 year | 1 cases | -87.5 % |
2021 year | 8 cases | +300 % |
2020 year | 2 cases | -50.0 % |
ウイルス filed 190 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 112 cases in total) is 18.7, and the median is 18.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2018 with 36 cases, and their lowest number in 2019 with 14 cases.
Index | Value |
---|---|
Average | 18.7 patents |
Std Dev | 11.0 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 19 cases | -26.92 % |
2021 year | 26 cases | +52.9 % |
2020 year | 17 cases | +21.43 % |
ウイルス filed 215 joint applications with ギリアードサイエンシーズインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 105 cases in total) is 17.5, and the median is 18.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 44 cases, and their lowest number in 2022 with 12 cases.
Index | Value |
---|---|
Average | 17.5 patents |
Std Dev | 9.9 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 12 cases | -58.6 % |
2021 year | 29 cases | +81.2 % |
2020 year | 16 cases | -20.00 % |
The following shows JP patents held by ウイルス that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and ウイルス’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which ウイルス is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 5 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.2 times. The most recently Invalidation Trial patent is 特許7185426 "S1P受容体モジュレーターの投与計画" (Invalidation Trial day 2023-07-10) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許7185426 | S1P受容体モジュレーターの投与計画 | 2023-07-10 |
2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
3 | 特許6203879 | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | 2022-09-30 |
4 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
5 | 特許6871663 | 次亜塩素酸水、次亜塩素酸水を調製するための組成物、及び次亜塩素酸水の判定用の試験紙 | 2021-11-18 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 8 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.1. The most invalidation trial patent is 特許6871663 "次亜塩素酸水、次亜塩素酸水を調製するための組成物、及び次亜塩素酸水の判定用の試験紙" (2 times) , and the next most invalidation trial patent is 特許6335326 "コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6871663 | 次亜塩素酸水、次亜塩素酸水を調製するための組成物、及び次亜塩素酸水の判定用の試験紙 | 2 times |
2 | 特許6335326 | コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用 | 1 times |
3 | 特許6896700 | ワクチン組成物 | 1 times |
4 | 特許6188984 | 抗ウイルス性衛生マスク | 1 times |
5 | 特許6203879 | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | 1 times |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 33 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7433217 "RNAウイルスの処理方法" (Opposition day 2024-08-15) , next is 特許7406226 "ウイルス不活性化剤" (Opposition day 2024-06-25) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7433217 | RNAウイルスの処理方法 | 2024-08-15 |
2 | 特許7406226 | ウイルス不活性化剤 | 2024-06-25 |
3 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
4 | 特許7338768 | 化粧シート | 2024-03-05 |
5 | 特許7329554 | 抗ウィルス性基体 | 2024-02-14 |
6 | 特許7291217 | 足場非依存性細胞およびその使用 | 2023-12-14 |
7 | 特許7289655 | PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
8 | 特許7240675 | オトフェルリンを発現させるための組成物および方法 | 2023-09-19 |
9 | 特許7229216 | 抗ウィルス部材 | 2023-08-28 |
10 | 特許7229215 | 抗ウィルス部材 | 2023-08-28 |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 95 patents Protest from third parties. The average number of Protest is 1.3 times. The most recently Protest patent is 特開2022-076642 "水性塗料、及び該水性塗料が塗装された物品" (Protest day 2024-09-05) , next is 特表2022-546587 "生物製剤の捕捉及び精製のための方法" (Protest day 2024-08-22) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2022-076642 | 水性塗料、及び該水性塗料が塗装された物品 | 2024-09-05 |
2 | 特表2022-546587 | 生物製剤の捕捉及び精製のための方法 | 2024-08-22 |
3 | 特開2023-157312 | エンベロープウイルス不活性化組成物 | 2024-08-06 |
4 | 特開2022-181793 | 抗菌・抗ウイルス性樹脂組成物およびそれを塗工した抗菌・抗ウイルス性塗工物 | 2024-08-05 |
5 | 特許7524213 | 下痢の防止及び処置における使用のためのビデンスピローサ及びそのファイトケミカル | 2024-08-01 |
6 | 特開2022-182798 | 抗ウイルス組成物 | 2024-07-30 |
7 | 特開2022-107358 | 二多段式駐車装置とその制御方法 | 2024-07-24 |
8 | 特開2021-154729 | 抗ウィルス性部材 | 2024-07-16 |
9 | 特開2023-062004 | 抗ウイルス性物品及び抗ウイルス性樹脂組成物 | 2024-07-09 |
10 | 特開2022-098204 | 抗ウィルス繊維構造体およびその製造方法、抗ウィルス加工製品 | 2024-07-05 |
11 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-06-15 |
12 | 特開2022-156870 | 抗菌・抗ウイルス剤組成物、物品、及び物品の製造方法 | 2024-06-10 |
13 | 特開2022-093225 | 抗菌・抗ウィルス性および防汚性を有するコーティング用組成物および塗工物 | 2024-05-30 |
14 | 特開2024-045453 | 殺ウイルス有効性に対するアニオン性界面活性剤の影響 | 2024-05-23 |
15 | 特開2024-051165 | バックアップ方法、情報処理装置およびプログラム | 2024-05-22 |
16 | 特開2023-171425 | 抗微生物基体 | 2024-04-30 |
17 | 特開2023-178310 | 抗微生物基体 | 2024-04-30 |
18 | 特開2022-088815 | 活性エネルギー線硬化性組成物及び床材 | 2024-03-21 |
19 | 特開2022-130161 | 抗コロナウイルス剤 | 2024-03-09 |
20 | 特開2022-026765 | ウイルス不活性化剤組成物 | 2024-03-08 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 171 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特開2022-182798 "抗ウイルス組成物" (6 times) , and the next most protest patent is 特許7123158 "水系塗料組成物、塗膜及び塗装物品" (5 times) .
- | No. | Title | |
---|---|---|---|
1 | 特開2022-182798 | 抗ウイルス組成物 | 6 times |
2 | 特許7123158 | 水系塗料組成物、塗膜及び塗装物品 | 5 times |
3 | 特許7316626 | カリシウイルス科ウイルス不活性化剤組成物及び衛生資材 | 5 times |
4 | 特許7092475 | 化粧板 | 5 times |
5 | 特許7080593 | 塗料組成物 | 5 times |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 342 patents Inspection from third parties. The average number of Inspection is 1.4 times. The most recently Inspection patent is 特表2022-511786 "新規芳香族化合物によるナチュラルキラー細胞およびILC3細胞の増殖" (Inspection day 2024-09-24) , next is 特表2021-502097 "標的化CRISPR送達プラットフォーム" (Inspection day 2024-09-17) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特表2022-511786 | 新規芳香族化合物によるナチュラルキラー細胞およびILC3細胞の増殖 | 2024-09-24 |
2 | 特表2021-502097 | 標的化CRISPR送達プラットフォーム | 2024-09-17 |
3 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-09-13 |
4 | 特表2022-543236 | エクソン44標的化核酸およびジストロフィンベースのミオパチーの治療のための当該核酸を含む組換えアデノ随伴ウイルス | 2024-09-12 |
5 | 特開2022-076642 | 水性塗料、及び該水性塗料が塗装された物品 | 2024-09-10 |
6 | 特表2022-526084 | 3次元定量的位相イメージングを用いる微生物の同定 | 2024-09-09 |
7 | 特表2021-519069 | 遺伝子改変リンパ球の製造方法 | 2024-09-06 |
8 | 特開2023-071635 | 分子標的薬nCoVshRNA・2ACE2の合成方法 | 2024-09-05 |
9 | 特許7427280 | 自動運転制御装置及び車両 | 2024-09-04 |
10 | 特許7470275 | 自動運転制御装置 | 2024-09-04 |
11 | 特開2023-157312 | エンベロープウイルス不活性化組成物 | 2024-09-03 |
12 | 特表2022-546587 | 生物製剤の捕捉及び精製のための方法 | 2024-08-28 |
13 | 特開2022-107358 | 二多段式駐車装置とその制御方法 | 2024-08-28 |
14 | 特表2021-525515 | 複数種の核酸試料を処理または分析するための組成物、方法およびシステム | 2024-08-22 |
15 | 特開2022-181793 | 抗菌・抗ウイルス性樹脂組成物およびそれを塗工した抗菌・抗ウイルス性塗工物 | 2024-08-20 |
16 | 特表2024-521164 | 感染後自己免疫性糖尿病を治療するための方法 | 2024-08-14 |
17 | 特表2022-544053 | 非枯渇性B細胞阻害剤によって免疫原性を低下させるための方法および組成物 | 2024-08-14 |
18 | 特開2023-030014 | チオールイソメラーゼ阻害剤およびその使用 | 2024-08-06 |
19 | 特開2022-182798 | 抗ウイルス組成物 | 2024-08-06 |
20 | 特許5586842 | 試料ろ過フィルターを用いる簡易メンブレンアッセイ方法及びキット | 2024-08-01 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 695 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特許6405339 "簡易メンブレンアッセイ法及びキット" (21 times) , and the next most inspection patent is 特許6405269 "簡易メンブレンアッセイ法及びキット" (18 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6405339 | 簡易メンブレンアッセイ法及びキット | 21 times |
2 | 特許6405269 | 簡易メンブレンアッセイ法及びキット | 18 times |
3 | 特許7080593 | 塗料組成物 | 10 times |
4 | 特開2021-116296 | コロナウイルス感染の治療におけるファビピラビルの使用 | 8 times |
5 | 特許7316626 | カリシウイルス科ウイルス不活性化剤組成物及び衛生資材 | 6 times |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 2,876 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特許6395765 "配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化" (35 times) , and the next most cited patent is 特許6778114 "イミド系タンパク質分解モジュレーター及び関連する使用方法" (32 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 35 times |
2 | 特許6778114 | イミド系タンパク質分解モジュレーター及び関連する使用方法 | 32 times |
3 | 特許6847053 | 選択的にウイルスに影響を及ぼすかおよび/またはそれを死滅させるための装置、方法およびシステム | 30 times |
4 | 特許6203879 | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | 26 times |
5 | 特許6352974 | ワクチンのための高力価組み換えインフルエンザ・ウィルス | 26 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International